Individual provider · Type 1 NPI
David Chang Ishizawar, MD
Advanced Heart Failure and Transplant Cardiology Physician · Raleigh, NC
Practice location
2800 Blue Ridge Rd Ste 204
Raleigh, NC 27607-6477
Other practice locations
- 9200 W Wisconsin Ave, Cardiovascular Medicine, Milwaukee, WI 53226-3522 · (414) 805-6633
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Advanced Heart Failure and Transplant Cardiology Physician | 207RA0001X | 65360 (WI) |
| Cardiovascular Disease Physician | 207RC0000X | MD434787 (PA) |
| Cardiovascular Disease Physician | 207RC0000X | 65360 (WI) |
| Advanced Heart Failure and Transplant Cardiology Physician Primary | 207RA0001X | 2023-02189 (NC) |
Advanced Heart Failure and Transplant Cardiology Physician: Specialists in Advanced Heart Failure and Transplant Cardiology would participate in the inpatient and outpatient management of patients with advanced heart failure across the spectrum from consideration for high-risk cardiac surgery, cardiac transplantation, or mechanical circulatory support, to pre-and post-operative evaluation and management of patients with cardiac transplants and mechanical support devices, and…
5 other providers at this address
- Rex Hospital IncAdvanced Heart Failure and Transplant Cardiology Physician Raleigh, NC NPI 1124694567
- Crystal Renee Keen, ANPAdult Health Nurse Practitioner Raleigh, NC NPI 1336333897
- Erica Jane Harberger Mountjoy, DNP, FNP-CFamily Nurse Practitioner Raleigh, NC NPI 1841754736
- Meaghan Lindsay Tordella, PA-CPhysician Assistant Raleigh, NC NPI 1871731877
- Rebecca Reeve Scarano, PA-CPhysician Assistant Raleigh, NC NPI 1467736553
Other advanced heart failure and transplant cardiology physician providers in Raleigh
About NPI 1326235607
David Chang Ishizawar, MD's National Provider Identifier is 1326235607, issued on Oct 1, 2007. The primary taxonomy on file is Advanced Heart Failure and Transplant Cardiology Physician (207RA0001X), and the practice location is in Raleigh, NC. The record was last updated on Oct 9, 2023.